semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Influenza Pandemic Influenza Subjects who Have an understanding of the study, agree to its provisions, and give written informed consent prior to study entry Are clinically healthy, as determined by the Investigator's clinical judgment through collection of medical history and performance of a physical examination Are physically and mentally capable of participating in the study Are willing to refrain from blood donation for the duration of Part A of the study (until Day 42 [= 21 days after the second vaccination]) Agree to keep a daily record of symptoms for the duration of the study If female and capable of bearing children have a negative urine pregnancy test result within 24 hours of the scheduled first vaccination and agree to employ adequate birth control measures for the duration of the study  Subjects will be excluded from participation in this study if they Have a history of exposure to H5N1 influenza virus or a history of vaccination with an H5N1 influenza vaccine Are at potential occupational risk of contracting H5N1 influenza infection (e.g., poultry workers) Suffer from or have a history of a significant neurological, cardiovascular, pulmonary (including asthma), hepatic, rheumatic, autoimmune, hematological, metabolic or renal disorder Have a Body Mass Index > 35 Have hypertension at screening that is graded as greater than Stage 1 (defined as a systolic pressure > 159 or diastolic pressure > 99) while seated and at rest (measurement shall be repeated twice before subject is excluded) Have clinically significant abnormal clinical laboratory values at screening as determined by the Investigator Have clinically significant electrocardiographic abnormalities at screening Test positive for HIV, HBcAb or HCV Suffer from any kind of immunodeficiency
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Asthma Eczema Allergy (mother) Pregnant women Living in Sealand, Denmark Fluent in Danish Language Willing to let the newborn child participate in the study  (mother) Participating in other clinical trial
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cystic Fibrosis Provision of informed consent prior to any study specific procedures Have a clinical diagnosis of cystic fibrosis with an FEV1 >40% of predicted normal Be able to comply with induced sputum procedure post-menopausal surgically sterile female (total hysterectomy and /or bilateral total oophorectomy)  Concomitant diagnosis of significant pulmonary disease other than CF-related lung disease, including symptomatic asthma and allergic bronchopulmonary aspergillosis Treatment with any immunomodulatory agents within 8 weeks prior to Visit 2 Known to be infected with Burkholderia cepacia
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.5-999.0,  Influenza Unvaccinated patients presenting to the Emergency Department aged 6 months or more who have at least one high risk attribute Age 6-59 months or >50 years Pregnant Health care worker Aged 6 months-18 years on chronic aspirin therapy Comorbidity (cardiovascular disease, pulmonary disease, metabolic disease, renal disease, hepatic disease, seizures, neuromuscular disease, cognitive dysfunction, or any reason to have had regular medical follow up or hospitalization in the preceding year) Household contact or caregiver of someone with at least one high risk attribute  Prior vaccination History of Guillan-Barre syndrome within 6 weeks of prior influenza vaccination Allergy to influenza vaccination or eggs Age < 6 months old Fever with more than minor illness Hospitalization
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Healthy to 80 years of age Good physical health based upon medical history and physical examination Willing and able to participate in the entire study duration Female subject with a negative urine pregnancy test immediately prior to study vaccination  Chronic skin infections or a chronic skin condition (e.g. psoriasis) Serious S. aureus infection in the last 12 months Allergy to aluminum-containing substance taken in the body or to any other vaccine component Oral temperature equal to or greater than 100.4ºF (38.0ºC), within the past 2 days Participation in a prior V710 vaccine clinical study Participation in any other clinical study in the past 4 weeks, or during the 3-month study duration
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Stress Healthy first-time mothers with singleton baby delivered at term with no complications  Mothers with chronic health problems Pregnancy complications, OR Infants with congenital problems or conditions requiring admission to the intensive care nursery
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Venous Thrombosis >18 years of age 2. Warrants prophylaxis against venous thromboembolism in pregnancy according to American College of Obstetrics and Gynecology Practice Bulletin 2000, reaffirmed in 2008 history of idiopathic thrombosis history of thrombosis related to pregnancy or oral contraceptive use history of thrombosis accompanied by an underlying thrombophilia other than homozygous for the factor V Leiden mutation, heterozygous for both the factor V Leiden and the prothrombin G20210A mutation, or AT-III deficiency without a history of thrombosis but who have an underlying thrombophilia and a strong family history of thrombosis Known thrombophilia except for those listed above, with a history of adverse pregnancy outcome (APO) as defined by: ¡Ý3 pregnancy losses in the 1st trimester, ¡Ý2 pregnancy losses/stillbirth in 2nd trimester, ¡Ý1 pregnancy loss/intrauterine fetal demise (IUFD) in the 3rd trimester, intrauterine growth restriction (IUGR), abruptio placentae, or severe pre-Eclampsia prior to 34 weeks gestation  Need for therapeutic-level anticoagulation as determined by physician 2. Renal disease as defined by serum creatinine >1.0 3. Weight >90kg 4. Allergy to enoxaparin
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 40.0-999.0,  Menopause Thrombophilia No previous exogenous estrogen exposure Symptomatic Menopause: hot flashes, sleep disturbance, or other symptoms related to estrogen deficiency Menopausal (see above)  History of bleeding or thrombotic disorder History of malignancy (particularly Breast Cancer) Diabetics Coronary Artery Disease Liver Disease Concurrent Anticoagulation therapy
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 20.0-75.0,  Hyperpigmentation Skin Aging Individuals who are willing to read and sign an informed consent form prior to participating in the study Individuals who have a temperature of less than or equal to 100 degrees F at the time of biopsy collection Individuals who had not applied any sunless tanning product on the arms within the past year Individuals with no prior history of alcoholism (or who consume fewer than 2 to 3 alcoholic beverages per day) Individuals who have not consumed any anti-aging nutritional supplements (multivitamins and multiminerals are acceptable) or aspirin, or other pain medication in the last 48 hours before biopsy  Male gender Individuals who did not fit the 'inclusion criteria' above
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Upper Respiratory Tract Infections Patients will be included if they have all the following Age ≥18 years old Patient has developed URTIs symptoms for 48 hours or less At least one from each of the following groups of URTIs symptoms Symptoms of infection: headache, chills, muscle ache, or an oral temperature greater than 37.5 degrees Celsius Symptoms from the upper respiratory tract: cough, hoarseness, running nose, nasal obstruction, itchy throat, sore throat or sneezing  Patients will be excluded from the study if they have one or more of the following Have symptoms of URTIs for more than 48 hours Pregnancy or breast-feeding Liver disease Known immune deficiency Alcohol (>30 units/wk) or drug abuse Medical history of asthma, allergic rhinitis, cystic fibrosis and chronic bronchopulmonary diseases Known allergies to food additives or study medications Taking chronic medications that contain any kind of herbs, mineral, or specific vitamin supplements Diabetes mellitus
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 50.0-999.0,  Cognitive Ability, General independent living older adult interested in strengthening exercise program  must meet Strong Bone's screening or have physician's approval
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-59.0,  Influenza Avian Influenza Male and female subjects will be eligible for participation in this study if they are 18 to 59 years of age, inclusive, on the day of screening have an understanding of the study and its procedures, agree to its provisions, and give written informed consent prior to study entry are generally healthy, as determined by the investigator's clinical judgment through collection of medical history and performance of a physical examination are physically and mentally capable of participating in the study and follow its procedures agree to keep a daily record of symptoms for the duration of the study if female of childbearing potential: have a negative urine pregnancy test result within 24 hours prior to the scheduled first vaccination and agree to employ adequate birth control measures for the duration of the study  Subjects will be excluded from participation in this study if they have a history of exposure to H5N1 virus or a history of vaccination with an H5N1 influenza vaccine are at high risk of contracting H5N1 influenza infection (e.g. poultry workers) currently have or have a history of a significant neurological, cardiovascular, pulmonary (including asthma), hepatic, metabolic, rheumatic, autoimmune, hematological or renal disorder have any inherited or acquired immunodeficiency have a disease or are currently undergoing a form of treatment or were undergoing a form of treatment within 30 days prior to study entry that can be expected to influence immune response. Such treatment includes, but is not limited to, systemic or high dose inhaled (> 800µg/day of beclomethasone dipropionate or equivalent) corticosteroids, radiation treatment or other immunosuppressive or cytotoxic drugs have a history of severe allergic reactions or anaphylaxis have a rash, dermatological condition or tattoos which may interfere with injection site reaction rating have received any blood products or immunoglobulins within 90 days prior to study entry have donated blood or plasma within 30 days prior to study entry
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Seasonal Influenza Subject is 18 to 59 years of age , inclusive, at the time of screening (for subjects in age stratum A only) Subject is 60 years of age or older , inclusive, at the time of screening (for subjects in age stratum B only) Subject has given written informed consent prior to study entry Subject is generally healthy , as determined by the investigator's clinical judgment through collection of medical history and performance of a physical examination, such that the investigator would not hesitate to provide routine influenza immunization to the subject in the course of routine medical practice Subject agrees to keep a daily record of symptoms for the duration of the study If female of childbearing potential, subject presents with a negative urine pregnancy test, and agrees to employ adequate birth control measures for the duration of the study Subject is willing and able to comply with the requirements of the protocol  Subject has a history of severe allergic reaction or anaphylaxis Subject has an oral temperature of >= 37.5°C on the day of vaccination in this study Subject has a rash or dermatologic condition or tattoos, which may interfere with injection site reaction rating Subject has received a live vaccine within 4 weeks or an inactivated or subunit vaccine within 2 weeks of study entry Subject has received a seasonal influenza vaccine within 6 months of study entry Subject currently has or had a history of a significant neurological, cardiovascular, pulmonary (including asthma), hepatic, metabolic, rheumatic, autoimmune, hematological or renal disorder Subject has any inherited or acquired immunodeficiency Subject has a disease or is currently undergoing a form of treatment or was undergoing a form of treatment within 30 days prior to study entry that can be expected to influence immune response. Such treatment includes, but is not limited to, systemic or high dose inhaled (>800 µg/day of beclomethasone dipropionate or equivalent) corticosteroids, radiation treatment or other immunosuppressive or cytotoxic drugs Subject has a functional or surgical asplenia Subject has a known or suspected problem with alcohol or drug abuse
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 40.0-70.0,  Menopause Women with menopausal Vasomotor symptoms (VMS) bothersome enough to warrant treatment; 2. Minimum of 7 hot flashes per day (on average); 3. Age limits: women ages 40-70 who have had at least one missed menstrual cycle or have undergone spontaneous menopause, women of any age who have medically induced menopause, women of any age who have had oophorectomy; 4. Informed written consent; 5. Ability to follow treatment protocols  (cohort): 1. Concomitant illness with reasonable likelihood of limiting survival to less than one year; 2. Current substance abuse (alcohol or drug); 3. Pregnancy known, suspected or planned in next year; 4. Non-English speaking patients 5. Men (TA intervention): 1. Other concomitant menopause treatment; 2. Participating in acupuncture treatment or formal psychological stress management program within the last year; 3. Participating in another treatment for VMS, unless willing to stop it 4 weeks in advance of participation; 4. HIV infection, chronic or active hepatitis or other blood-borne illness
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 40.0-70.0,  Menopause Women with menopausal VMS bothersome enough to warrant treatment; 2. Minimum of 7 hot flashes per day (on average); 3. Age limits: women ages 40-70 who have had at least one missed menstrual cycle or have undergone spontaneous menopause, women of any age who have medically induced menopause, women of any age who have had oophorectomy; 4. Informed written consent; 5. Ability to follow treatment protocols  (cohort) 1. Concomitant illness with reasonable likelihood of limiting survival to less than one year; 2. Current substance abuse (alcohol or drug); 3. Pregnancy known, suspected or planned in next year (TA intervention) 1. Other concomitant menopause treatment; 2. Participating in acupuncture treatment or formal psychological stress management program within the last year; 3. Participating in another treatment for VMS, unless willing to stop it 4 weeks in advance of participation; 4. HIV infection, chronic or active hepatitis or other blood-borne illness
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Brain and Central Nervous System Tumors Chronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Nonmalignant Neoplasm Viral Infection Meets 1 of the following Patient at City of Hope or Kaiser hospital who underwent prior autologous or allogeneic matched-related hematopoietic stem cell transplantation (HSCT) or matched-unrelated HSCT for treatment of hematological malignancies, including aplastic anemia or myelodysplastic syndromes Must agree to return to City of Hope for screening every 2-4 weeks during the flu season 365 days post-transplant Any prior therapy allowed Employee volunteer from the City of Hope who agrees to have a nasopharyngeal wash performed at General Clinical Research Center every 2 weeks during the flu season Must be eligible (per physicians instructions) and vaccinated during the 2008-2009 or 2009-2010 flu season Life expectancy > 9 months PRIOR See Disease Characteristics
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-1.0,  Car Seat Transition for At-risk Infants All infants who visit Children's Hospital Boston, Center for Healthy Infant Lung Development for follow up car seat testing  None